Abbie Celniker, the CEO of Cambridge, Mass.-based Taligen Therapeutics, is the newest member on the board of directors at the Massachusetts Life Sciences Center.
Massachusetts Governor Deval Patrick made his appointment of the former Novartis Global Head of Biologics final on June 29.
Celniker is also serving as co-chair of the Massachusetts Biomanufacturing Roundtable, an initiative of the multi-sector Massachusetts Life Sciences Collaborative, which received a $50,000 grant from from the Mass. Life Sciences Center on July 23.
The Commonwealth created the MLSC to spend the $1 billion alocated by the governor’s 2006 life sciences bill.
The quasi-public agency awarded $2.5 million in accelerator loans to four early-stage life science companies and $1.5 million in so-called Small Business Matching Grants to three other life science firms in June.